E

Everest Medicines Ltd
HKEX:1952

Watchlist Manager
Everest Medicines Ltd
HKEX:1952
Watchlist
Price: 46.5 HKD -0.75% Market Closed
Market Cap: 15.2B HKD
Have any thoughts about
Everest Medicines Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
Everest Medicines Ltd

Wall Street analysts forecast Everest Medicines Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Everest Medicines Ltd is 31.89 HKD with a low forecast of 24.75 HKD and a high forecast of 59.01 HKD.

Lowest
Price Target
24.75 HKD
47% Downside
Average
Price Target
31.89 HKD
31% Downside
Highest
Price Target
59.01 HKD
27% Upside
Everest Medicines Ltd Competitors:
Price Targets
PAR
Paradigm Biopharmaceuticals Ltd
23% Upside
006280
Green Cross Corp
17% Upside
CPRX
Catalyst Pharmaceuticals Inc
55% Upside
ASND
Ascendis Pharma A/S
44% Upside
SPRY
ARS Pharmaceuticals Inc
165% Upside
2487
Cutia Therapeutics
123% Upside
BIOCON
Biocon Ltd
5% Upside
HPHA
Heidelberg Pharma AG
408% Upside

Revenue
Forecast

Revenue Estimate
Everest Medicines Ltd

The compound annual growth rate of Everest Medicines Ltd's revenue for the next 4 years is 130%.

N/A
Past Growth
130%
Estimated Growth
Estimates Accuracy
-97%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Everest Medicines Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-11%
Average Miss

Net Income
Forecast

Net Income Estimate
Everest Medicines Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Everest Medicines Ltd's stock price target?
Price Target
31.89 HKD

According to Wall Street analysts, the average 1-year price target for Everest Medicines Ltd is 31.89 HKD with a low forecast of 24.75 HKD and a high forecast of 59.01 HKD.

What is Everest Medicines Ltd's Revenue forecast?
Projected CAGR
130%

The compound annual growth rate of Everest Medicines Ltd's revenue for the next 4 years is 130%.

Back to Top